About Renovis
Renovis is a company based in San Francisco (United States) founded in 2000 was acquired by Evotec in September 2007.. Renovis has raised $45 million across 4 funding rounds from investors including Evotec, Flagship Pioneering and HBM Healthcare Investments. The company has 368 employees as of December 31, 2020. Renovis offers products and services including CRO/CDMO Services, Pipeline Co-Creation, and PanOmics Platform. Renovis operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others.
- Headquarter San Francisco, United States
- Employees 368 as on 31 Dec, 2020
- Stage Public
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Renovis, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Renovis
Renovis offers a comprehensive portfolio of products and services, including CRO/CDMO Services, Pipeline Co-Creation, and PanOmics Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers contract research for drug development and manufacturing.
Facilitates collaborative drug discovery programs.
Utilizes AI for better disease understanding and research.
Funding Insights of Renovis
Renovis has successfully raised a total of $45M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $2 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $2.0M
-
First Round
First Round
(11 Aug 2003)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2014 | Amount | Post-IPO - Renovis | Valuation |
investors |
|
| Jun, 2013 | Amount | Post-IPO - Renovis | Valuation |
investors |
|
| Feb, 2012 | Amount | Post-IPO - Renovis | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Renovis
Renovis has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Evotec, Flagship Pioneering and HBM Healthcare Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Renovis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Renovis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Renovis Comparisons
Competitors of Renovis
Renovis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Neurocrine, PTC Therapeutics and Biohaven Pharmaceutical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Renovis
When was Renovis founded?
Renovis was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Where is Renovis located?
Renovis is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Renovis a funded company?
Renovis is a funded company, having raised a total of $45M across 4 funding rounds to date. The company's 1st funding round was a Post-IPO of $3.47M, raised on Aug 11, 2003.
How many employees does Renovis have?
As of Dec 31, 2020, the latest employee count at Renovis is 368.
What does Renovis do?
Founded in 2000 and based in San Francisco, United States, Renovis is involved in the discovery, development, and commercialization of pharmaceuticals targeting neurological conditions, including acute ischemic stroke, neuropathic pain, and post-operative pain. Preclinical efforts and research in pain management and neuroinflammation are maintained, alongside specialized chemistry applications. Centaur Pharmaceuticals was acquired by the company in 2003 for an undisclosed sum.
Who are the top competitors of Renovis?
Renovis's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Renovis offer?
Renovis offers CRO/CDMO Services, Pipeline Co-Creation, and PanOmics Platform.
Who are Renovis's investors?
Renovis has 11 investors. Key investors include Evotec, Flagship Pioneering, HBM Healthcare Investments, Easton Capital Investment Group, and Healthcap.